Please login to the form below

Not currently logged in
Email:
Password:

Consilium Strategic Communications wins Vectura account

Will advise on financial and corporate PR following SkyePharma merger

Consilium Strategic CommunicationsConsilium Strategic Communications has been selected by Vectura to advise on its international financial and corporate PR dealings, following the completion of its £441m merger with SkyePharma.

The London-based healthcare strategic communications will work with Vectura as it implements its business plan to become an industry-leading respiratory specialist, under the purview of former AstraZeneca executive James Ward-Lilley.

Consilium's Mary-Jane Elliott, Susan Stuart, Jessica Hodgson, Chris Welsh and Melissa Gardiner will have central roles in directing Vectura's PR strategy.

Commenting on the partnership, co-founder managing partner of Consilium Elliot said: “We are delighted to be working with Vectura during such an exciting time for the company and since its merger with Skyepharma.

“Vectura aims to establish its position as the new UK-based international inhaled airways disease-focused powerhouse and we look forward to helping them build the new Vectura story.”

Article by
Rebecca Clifford

23rd September 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics